PriMED Clinical Research Study on Flu Prevention
Study Name: Flu Prevention Study
Purpose: The flu can be serious, especially for people who are older, have certain health conditions, or have a weakened immune system. Flu vaccines help, but they may not protect everyone. Researchers are studying a medicine called MK-1406 (CD388) to see if it can help prevent the flu. It is a long-acting anti-viral, that may help stop the flu virus from replicating. The study is for teens and adults who may have a higher chance of becoming very sick from the flu. It may be given with or without the flu vaccine.
What to Expect in Clinical Trial:
If you choose to join:
• You will receive either MK-1406 or a placebo. A placebo does not contain study medicine.
• You will receive three shots under the skin during one study visit.
• Neither you nor the study team will know which treatment you receive until the study is complete.
• The study team will explain what to expect, answer your questions, and monitor your health and safety.
Taking part is your choice. Researchers hope this study will help them learn whether MK-1406 is safe and can help protect people from the flu.
Location: PriMED Clinical Research
FAQs
Why are we offering this option?
We believe this study will potentially benefit our patients and future patients.
What will happen in the study?
You will be asked to come into our Research Clinic to participate. All study procedures and assessments will be at no cost to you or your insurance.
Will I or my child be paid to participate in this research study?
Participants may receive compensation for their time and travel expenses.
Where will these visits be located?
Visits will be located at our PriMED Clinical Research office:
PriMED Clinical Research
3080 Ackerman Blvd, Suite 210
Dayton, Ohio 45429
How can I learn more information or sign up?
If you are interested in learning more about how to sign up for the PriMED Clinical Research, please call (937) 534-4201 and speak to a member of the research team, or simply fill out our online interest form.